000960 China Merchants Pharmaceutical Health Industry Stock Fund

000960 is the stock code of China Merchants Pharmaceutical Health Industry Stock Fund. China Merchants Health Industry Investment Co., Ltd. was established on July 3, 20 18. The legal representative is Yu Shixin, and the business scope of the company includes: investing in medicine, medical treatment and health care industries with its own funds (not engaging in legal financial business or engaging in disguised form); Technical development, transfer, consultation and service of pharmaceutical products; Wholesale and retail of medicinal materials, medicines (limited to branch operations), medical devices (limited to branch operations), mechanical equipment and electromechanical equipment; Self-operated and agent for the import and export of goods and technologies.

Stock investment strategy

The fund's stock investment adopts a bottom-up approach, based on in-depth fundamental research, and through in-depth fundamental research and analysis, it selects high-quality listed companies with good fundamentals, good development prospects and undervalued in medical and health industries and related industries to actively invest and build stock portfolios and bond portfolios.

1, the definition of medical and health industry stocks

The medical and health industry referred to in this Fund consists of companies engaged in research and development, production or sales of medical and health-related products or services, including but not limited to chemical pharmaceutical industry, traditional Chinese medicine industry, biological products industry, pharmaceutical business industry, medical device industry and medical service industry.

2. Industry allocation strategy

According to the types of products and services provided, the medical and health industry can be divided into different sub-industries. The Fund will comprehensively consider economic factors, social factors and policy factors, market demand trends, industry competition pattern, technical level and development trends, and allocate stock assets among various sub-industries.

3. Individual stock selection

On the basis of industry allocation, the Fund comprehensively evaluates the investment value of listed companies in the medical and health industry by considering the following factors: endogenous growth factors (such as product competitive advantage, product life cycle, sales ability, management ability, research and development ability, growth potential, profitability, financial institutions, corporate governance structure, etc.). ) and exogenous growth factors (such as overall listing, mergers and acquisitions, etc. ). On this basis, the Fund will select listed companies with strong competitive advantages.